INNO Trades Steady, Outperforms the CSE25 and HMMJ Marijuana ETF$INNO.CN stock grew by +3.39% on Friday, stock opened at $0.590 and closed at $0.610, meanwhile price action is working above 20 EMA in daily chart that shows stock is bullish in nature and MACD is also showing strength in stock. RSI is close to par, indicating that current share price is fairly val
−0.0063 USD
−1.75 M USD
28.02 M USD
221.94 M
About INNOCAN PHARMA CORPORATION
Sector
Industry
CEO
Iris Or Gabi Bincovich
Website
Headquarters
Calgary
Founded
2018
FIGI
BBG00YB9B2M2
InnoCan Pharma Corp. operates as a pharmaceutical tech company. It operates through the Online Sales and Other Operations segments. The Online Sales segment engages in the development of non-CBD personal care and beauty products in the United States for online platforms such as Amazon, and other e-commerce retail sales. The Other Operations segment involves in the development of several drug delivery platforms, combining cannabinoids with other pharmaceutical ingredients as well as the development and sale of CBD-integrated topical products. The company was founded in October 2017 and is headquartered in Alberta, Canada.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of INNPF is 0.1400 USD — it has increased by 6.06% in the past 24 hours. Watch Innocan Pharma Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Innocan Pharma Corp. stocks are traded under the ticker INNPF.
INNPF reached its all-time high on Sep 16, 2021 with the price of 1.2706 USD, and its all-time low was 0.0908 USD and was reached on Sep 25, 2024. View more price dynamics on INNPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INNPF stock is 5.71% volatile and has beta coefficient of 0.53. Track Innocan Pharma Corp. stock price on the chart and check out the list of the most volatile stocks — is Innocan Pharma Corp. there?
Today Innocan Pharma Corp. has the market capitalization of 33.18 M, it has decreased by −4.98% over the last week.
Yes, you can track Innocan Pharma Corp. financials in yearly and quarterly reports right on TradingView.
INNPF net income for the last quarter is −110.78 K USD, while the quarter before that showed −292.33 K USD of net income which accounts for 62.10% change. Track more Innocan Pharma Corp. financial stats to get the full picture.
No, INNPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Innocan Pharma Corp. EBITDA is −1.16 M USD, and current EBITDA margin is −4.12%. See more stats in Innocan Pharma Corp. financial statements.
Like other stocks, INNPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innocan Pharma Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Innocan Pharma Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Innocan Pharma Corp. stock shows the sell signal. See more of Innocan Pharma Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.